Rare Disease Drugs Market Growth Driven by Biologics, Gene Therapies, and Rising Orphan Drug Approvals
The global Rare Disease Drugs Market is experiencing remarkable growth as healthcare systems, pharmaceutical companies, and regulatory agencies increasingly focus on addressing unmet medical needs. Rare diseases, often referred to as orphan diseases, affect a relatively small percentage of the population. However, collectively they impact millions of people worldwide. The growing...
0 Σχόλια 0 Μοιράστηκε 7 Views 0 Προεπισκόπηση